CC BY 4.0 · Facial Plast Surg 2018; 34(05): 545-550
DOI: 10.1055/s-0038-1672213
Rapid Communication
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

A 2-Year Follow-up Study of an Absorbable Implant to Treat Nasal Valve Collapse

Marion San Nicoló
1   Department of Otorhinolaryngology, Head and Neck Surgery, Ludwig Maximilian University of Munich, Munich, Germany
,
Klaus Stelter
2   HNO Zentrum Mangfall-Inn, Rosenheim, Germany
,
Haneen Sadick
3   Division of Facial Plastic Surgery, Department of Otorhinolaryngology, University of Mannheim, Mannheim, Germany
,
Murat Bas
4   Private Practice, Ottobrunn, Germany
,
Alexander Berghaus
1   Department of Otorhinolaryngology, Head and Neck Surgery, Ludwig Maximilian University of Munich, Munich, Germany
› Author Affiliations
Funding This study was supported with research funding from Spirox Inc., Redwood City, CA. Dr. San Nicoló is consultant to Spirox.
Further Information

Publication History

Publication Date:
18 September 2018 (online)

Abstract

The safety and effectiveness of an absorbable implant for lateral cartilage support have been recently demonstrated in subjects with nasal valve collapse (NVC) at 12 months postprocedure. This follow-up study aimed to assess whether the safety and effectiveness of the implant persist in these patients for 24 months after the procedure. Thirty subjects with Nasal Obstruction Symptom Evaluation (NOSE) score ≥ 55 and isolated NVC were treated; 14 cases were performed in an operating suite under general anesthesia and 16 cases were performed in a clinic-based setting under local anesthesia. The implant, a polylactic acid copolymer, was placed with a delivery tool within the nasal wall to provide lateral cartilage support. Subjects were followed up through 24 months postprocedure. Fifty-six implants were placed in 30 subjects. The mean preoperative NOSE score was 76.7 ± 14.8, with a range of 55 to 100. At 24 months, the mean score was 32.0 ± 29.3, reflecting an average within-patient reduction of −44.0 ± 31.1 points. There were no device-related adverse events in the 12 to 24 months period. There were five subjects who exited the study prior to the 24-month follow-up. Four of the five subjects who exited were elected for further intervention and one subject was lost to follow-up. This study demonstrates safety of an absorbable implant for lateral nasal wall support and symptom improvement in some subjects with NVC at 24 months postprocedure.

 
  • References

  • 1 Rhee JS, Book DT, Burzynski M, Smith TL. Quality of life assessment in nasal airway obstruction. Laryngoscope 2003; 113 (07) 1118-1122
  • 2 Bhattacharyya N. Ambulatory sinus and nasal surgery in the United States: demographics and perioperative outcomes. Laryngoscope 2010; 120 (03) 635-638
  • 3 Most SP. Trends in functional rhinoplasty. Arch Facial Plast Surg 2008; 10 (06) 410-413
  • 4 Most SP. Comparing methods for repair of the external valve: one more step toward a unified view of lateral wall insufficiency. JAMA Facial Plast Surg 2015; 17 (05) 345-346
  • 5 Stewart MG, Smith TL, Weaver EM. , et al. Outcomes after nasal septoplasty: results from the Nasal Obstruction Septoplasty Effectiveness (NOSE) study. Otolaryngol Head Neck Surg 2004; 130 (03) 283-290
  • 6 Lavinsky-Wolff M, Camargo Jr HL, Barone CR. , et al. Effect of turbinate surgery in rhinoseptoplasty on quality-of-life and acoustic rhinometry outcomes: a randomized clinical trial. Laryngoscope 2013; 123 (01) 82-89
  • 7 Sheen JH. Spreader graft: a method of reconstructing the roof of the middle nasal vault following rhinoplasty. Plast Reconstr Surg 1984; 73 (02) 230-239
  • 8 Toriumi DM, Josen J, Weinberger M, Tardy Jr ME. Use of alar batten grafts for correction of nasal valve collapse. Arch Otolaryngol Head Neck Surg 1997; 123 (08) 802-808
  • 9 Akcam T, Friedman O, Cook TA. The effect on snoring of structural nasal valve dilatation with a butterfly graft. Arch Otolaryngol Head Neck Surg 2004; 130 (11) 1313-1318
  • 10 Gunter JP, Friedman RM. Lateral crural strut graft: technique and clinical applications in rhinoplasty. Plast Reconstr Surg 1997; 99 (04) 943-952 , discussion 953–955
  • 11 Winkler AA, Soler ZM, Leong PL, Murphy A, Wang TD, Cook TA. Complications associated with alloplastic implants in rhinoplasty. Arch Facial Plast Surg 2012; 14 (06) 437-441
  • 12 Ramakrishnan JB, Danner CJ, Yee SW. The use of porous polyethylene implants to correct nasal valve collapse. Otolaryngol Head Neck Surg 2007; 136 (03) 357-361
  • 13 Berghaus A. Implants for reconstructive surgery of the nose and ears. GMS Curr Top Otorhinolaryngol Head Neck Surg 2007; 6: Doc06
  • 14 San Nicoló M, Stelter K, Sadick H, Bas M, Berghaus A. Absorbable implant to treat nasal valve collapse. Facial Plast Surg 2017; 33 (02) 233-240
  • 15 Stewart MG, Witsell DL, Smith TL, Weaver EM, Yueh B, Hannley MT. Development and validation of the Nasal Obstruction Symptom Evaluation (NOSE) scale. Otolaryngol Head Neck Surg 2004; 130 (02) 157-163
  • 16 Barone M, Cogliandro A, Di Stefano N, Tambone V, Persichetti P. A systematic review of patient-reported outcome measures after rhinoplasty. Eur Arch Otorhinolaryngol 2017; 274 (04) 1807-1811
  • 17 Floyd EM, Ho S, Patel P, Rosenfeld RM, Gordin E. Systematic review and meta-analysis of studies evaluating functional rhinoplasty outcomes with the NOSE score. Otolaryngol Head Neck Surg 2017; 156 (05) 809-815
  • 18 Lipan MJ, Most SP. Development of a severity classification system for subjective nasal obstruction. JAMA Facial Plast Surg 2013; 15 (05) 358-361
  • 19 Rhee JS, Weaver EM, Park SS. , et al. Clinical consensus statement: diagnosis and management of nasal valve compromise. Otolaryngol Head Neck Surg 2010; 143 (01) 48-59
  • 20 Becker SS, Dobratz EJ, Stowell N, Barker D, Park SS. Revision septoplasty: review of sources of persistent nasal obstruction. Am J Rhinol 2008; 22 (04) 440-444
  • 21 Rippy MK, Baron S, Rosenthal M, Senior BA. Evaluation of absorbable PLA nasal implants in an ovine model. Laryngoscope Investig Otolaryngol 2018; 3 (03) 156-161